AHA Coding Clinic® for HCPCS - 2022 Issue 2; Ask the Editor
Discontinued monoclonal antibody infusion
A patient with mild COVID-19 symptoms presented for an outpatient infusion of the monoclonal antibody treatment casirivimab and imdevimab. The infusion was initiated and after seven minutes with an infusion of 17mL of the medication, the patient chose to discontinue the treatment and left the facility declining post infusion observation. Is it appropriate to append a Modifier 52, Reduced Services, to HCPCS Level II code M0243 if the infusion was discontinued due to patient decision with no post-infusion monitoring? ...
To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.
Thank you for choosing Find-A-Code, please Sign In to remove ads.